|
Discovery of therapeutic antibodies targeting breast cancer metastasis using Enabled G-Protein-Coupled Receptors
|
1R43CA213832-01
|
$300,000
|
$300,000
|
MILENI, MAURO
|
ABILITA BIO, INC.
|
|
Antibody targeting of ADAM8 for treatment of triple-negative breast cancer
|
1R41CA200161-01A1
|
$300,000
|
$300,000
|
SONENSHEIN, GAIL
|
ADECTO PHARMACEUTICALS, INC.
|
|
Antibody targeting of ADAM8 for treatment of triple-negative breast cancer
|
3R41CA200161-01A1S1
|
$63,490
|
$63,490
|
SONENSHEIN, GAIL
|
ADECTO PHARMACEUTICALS, INC.
|
|
Integrin Regulation of Cancer Progression Through Alternative mRNA Splicing and Nonsense-Medidated Decay (NMD)
|
2R01CA129637-06A1
|
$375,250
|
$375,250
|
DIPERSIO, C. MICHAEL
|
ALBANY MEDICAL COLLEGE
|
|
Signal transduction regulating tumor cell dissemination
|
2R01CA150344-28
|
$396,625
|
$396,625
|
CONDEELIS, JOHN
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
Roles of formins in breast cancer invasion
|
1R21CA205262-01
|
$181,613
|
$181,613
|
HODGSON, LOUIS
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
MOTILITY AND INVASION
|
5P01CA100324-14
|
$2,028,990
|
$2,028,990
|
CONDEELIS, JOHN
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Core Support for Cancer Center
|
3P30CA013330-44S1
|
$199,871
|
$35,977
|
GOLDMAN, ISRAEL
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Core Support for Cancer Center
|
3P30CA013330-44S2
|
$199,989
|
$35,998
|
GOLDMAN, ISRAEL
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Core Support for Cancer Center
|
3P30CA013330-44S3
|
$500,000
|
$90,000
|
GOLDMAN, ISRAEL
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Core Support for Cancer Center
|
5P30CA013330-44
|
$3,746,138
|
$674,305
|
GOLDMAN, ISRAEL
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
The role of tunneling nanotubes as a novel mode of tumor cell-macrophage communication
|
1F99CA212451-01
|
$45,076
|
$45,076
|
HANNA, SAMER
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Inhibition of Senescence to Increase Cancer Cell Death: A New Paradigm
|
5R01CA077263-17
|
$413,086
|
$136,318
|
MCDAID, HAYLEY
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
The Metastatic Cascade: Macrophages Lead the Way
|
5R01CA172451-05
|
$439,400
|
$145,002
|
POLLARD, JEFFREY
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
The B7x pathway in the tumor microenvironment
|
5R01CA175495-04
|
$346,525
|
$69,305
|
ZANG, XINGXING
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Combinatorial Inactivation of ERBB Receptors in Breast Cancer using Therapeutic Stapled Peptides
|
1R41CA203353-01
|
$300,000
|
$300,000
|
CAMENISCH, TODD
|
ARIZONA CANCER THERAPEUTICS, LLC
|
|
Novel approaches to study immune responses to post translational modifications for cancer detection
|
1U01CA214201-01
|
$480,733
|
$240,367
|
LABAER, JOSHUA
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
Couple Communication in Cancer: A Multi-Method Examination
|
1R01CA201179-01A1
|
$693,817
|
$346,909
|
LANGER, SHELBY
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
Effects of Meditative Movement (Qigong/Tai Chi Easy) On Fatigued Breast Cancer Survivors.
|
3R01CA182901-02S1
|
$62,505
|
$62,505
|
LARKEY, LINDA
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
Effects of Meditative Movement (Qigong/Tai Chi Easy) on Fatigued Breast Cancer Survivors
|
5R01CA182901-02
|
$626,062
|
$626,062
|
LARKEY, LINDA
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
PNNL Proteome Characterization Center
|
1U24CA210955-01
|
$1,123,778
|
$370,847
|
LIU, TAO
|
BATTELLE PACIFIC NORTHWEST LABORATORIES
|
|
Risk Prediction for ER Negative Breast Cancer Recurrence
|
4R01CA172511-04
|
$614,362
|
$614,362
|
BONDY, MELISSA
|
BAYLOR COLLEGE OF MEDICINE
|
|
Investigating the mechanisms of CD44s splice isoform in breast cancer metastasis
|
7R01CA182467-04
|
$301,150
|
$301,150
|
CHENG, CHONGHUI
|
BAYLOR COLLEGE OF MEDICINE
|
|
Role of Sympathetic Activation and RANKL/IL6 in Breast Cancer Bone Metastasis
|
7R01CA168717-04
|
$323,700
|
$323,700
|
ELEFTERIOU, FLORENT
|
BAYLOR COLLEGE OF MEDICINE
|
|
Integration of Predictive Biomarkers of Hormone Resistance in Breast Cancer
|
5R01CA072038-18
|
$320,963
|
$320,963
|
FUQUA, SUZANNE
|
BAYLOR COLLEGE OF MEDICINE
|
|
Epigenomic reprogramming driven by mutant ER? in metastatic breast cancer
|
1F31CA210385-01
|
$43,525
|
$43,525
|
GATES, LEAH
|
BAYLOR COLLEGE OF MEDICINE
|
|
Elucidating the functions of Bud31, an essential gene in Myc-driven breast cancer
|
4F30CA180447-04
|
$39,505
|
$39,505
|
HSU, TIFFANY
|
BAYLOR COLLEGE OF MEDICINE
|
|
The cell of origin of breast cancer metastasis
|
1R21CA202227-01
|
$172,369
|
$172,369
|
LI, YI
|
BAYLOR COLLEGE OF MEDICINE
|
|
New mechanisms of breast cancer metastasis and loss of estrogen receptor driven by 14-3-3
|
1R21CA198041-01A1
|
$206,843
|
$206,843
|
LIN, WEEI-CHIN
|
BAYLOR COLLEGE OF MEDICINE
|
|
Translational control of EMT by the CELF1 RNA Binding Protein
|
5R01CA190467-02
|
$362,569
|
$362,569
|
NEILSON, JOEL
|
BAYLOR COLLEGE OF MEDICINE
|
|
Prospective Identification of Translational Regulators in EMT
|
5R21CA185769-02
|
$172,369
|
$172,369
|
NEILSON, JOEL
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-10S1
|
$118,016
|
$27,144
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-10S2
|
$170,897
|
$39,306
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-10S3
|
$118,875
|
$27,341
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-10S4
|
$499,947
|
$114,988
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-10S5
|
$134,220
|
$30,871
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Translational Research in Breast Cancer (SPORE)
|
3P50CA186784-03S1
|
$750,000
|
$750,000
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
5P30CA125123-10
|
$3,253,119
|
$748,217
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Translational Research in Breast Cancer (SPORE)
|
5P50CA186784-03
|
$2,161,998
|
$2,161,998
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Hormonal Regulation of Breast Cancer
|
4R01CA016303-41
|
$800,980
|
$800,980
|
ROSEN, JEFFREY
|
BAYLOR COLLEGE OF MEDICINE
|
|
Delineating racially distinct metabolic pathways in triple negative breast cancer
|
5U01CA179674-03
|
$335,246
|
$335,246
|
SREEKUMAR, ARUN
|
BAYLOR COLLEGE OF MEDICINE
|
|
Discovering genetic networks of triple-negative breast cancer
|
4R01CA178039-04
|
$324,738
|
$324,738
|
WESTBROOK, THOMAS
|
BAYLOR COLLEGE OF MEDICINE
|
|
The Role of SRC-1 in Breast Cancer
|
4R01CA112403-10
|
$269,732
|
$269,732
|
XU, JIANMING
|
BAYLOR COLLEGE OF MEDICINE
|
|
iPGDAC, An Integrative Proteogenomic Data Analysis Center for CPTAC
|
1U24CA210954-01
|
$1,004,827
|
$331,593
|
ZHANG, BING
|
BAYLOR COLLEGE OF MEDICINE
|
|
Osteoclast-independent mechanisms of early-stage bone colonization of breast canc
|
5R01CA183878-03
|
$324,738
|
$324,738
|
ZHANG, XIANG
|
BAYLOR COLLEGE OF MEDICINE
|
|
Discovery and Characterization of Mutations in Breast and Ovarian Cancers
|
1R50CA211280-01
|
$215,047
|
$107,524
|
ADAMSON, AARON
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Germline and Tumor Genomic Analyses of Breast Cancer in Latinas
|
5R01CA184585-03
|
$817,565
|
$817,565
|
NEUHAUSEN, SUSAN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Cancer Center Support Grant
|
3P30CA033572-33S1
|
$125,651
|
$11,309
|
ROSEN, STEVEN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Cancer Center Support Grant
|
3P30CA033572-33S2
|
$124,999
|
$11,250
|
ROSEN, STEVEN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Cancer Center Support Grant
|
3P30CA033572-33S3
|
$37,400
|
$3,366
|
ROSEN, STEVEN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
Total relevant funding to Breast for this search: $520,138,871
|